Enterprise-scale deployments are expanding, but adoption is still deliberate. Understanding who actually buys — and why — is critical for founders. Advances in AI continue to outpace adoption in U.S. hospitals. Large language models (LLMs) have improved rapidly, yet hospital purchasing remains guided by governance, workflow fit, measurable ROI, and regulatory constraints. Early 2026 is not a reset. New launches from ChatGPT Health and Claude for Healthcare have raised expecta

Insights on funding, commercialization, and adoption trends that will determine which solutions succeed in the U.S. digital health and medical devices market in 2026. This article synthesizes what actually happened in 2025—and what U.S. buyers are signaling they will reward next. Capital Tells the Truth Capital signals in 2025 were not uniform—and that distinction matters for global founders. IPOs, private funding, and M&A each reflected different tolerances for risk, buyer r

For tech startups worldwide—whether in SaaS, eCommerce, or healthtech—the US market represents both opportunity and risk. Its size, funding depth, and rapid technology adoption make it attractive, but only for companies that are strategically ready to scale. This post focuses on why the US market can improve your startup’s odds of success and how factors like your stage and sector influence the potential benefits. The US Market as a Growth Lever The United States is not just